Preparing Vaxzevria Vaccine in Trusts

Mark Cheeseman, Professional Lead for Medicines Information, Midlands & East, Midlands and East Medicines Advice Service (East site)Published Last updated See all updates

Resources to support the Vaxzevria Vaccine are provided including: standard operating procedures, work instructions and a checklist.

Purpose

Attached to this page are:

  • A standard operating procedure describing preparation of the vaccine.
  • A preparation work instruction sheet for the vaccine.
  • A supervision checklist for preparation of the vaccine.

Presentation

The attachment is presented in Word to enable adaptation locally, or as reference source to check that existing local procedures are robust and comprehensive.
Within the SOP:

  • GREEN TEXT indicates that detail is awaited, and will be added when available;
  • RED TEXT indicates where detail is to be added locally.

Attachments

Other handling content for Trusts

Other COVID-19 vaccines resources

Change history

  1. Removal of reference to Regulation 174 product and updated throughout to reflect change in name for the licensed product (Vaxzevria).
  1. Resources checked and information remains correct.
  1. AZH3 Reference to Public Health England or PHE amended to UK Health Security Agency or UKHSA, added sentence to check the vial is within the manufacturers expiry printed on the vial, and references updated. AZH3.1 Added sentence to check the vial is within the manufacturers expiry printed on the vial.
  1. Resources checked and information remains correct.
  1. Resources checked and information remains correct.
  1. AZH3 Amended to state that outer packaging must be disposed of as confidential waste.
  1. AZH3 4.3.13 Change of zero character with Celsius character.
  2. AZH3 Wording amended in section 4.3.12 to 4.3.14 for clarity on actions required.
  1. AZH3 Wording amended on section 4.3.14 to 4.3.15 providing further clarity on actions required.
  2. AZH3.1 Picture of syringe updated
  1. Clarification of wording about removing of vaccine vials from refrigerator.
  2. Avoidance of pooling added.
  3. Amended needle gauge options for morbidly obese patients in accordance with PHE guidance.
  1. Clarification on working under the national PGD and inclusion of extra consumables for additional doses incorporated into main text.
  1. Withdrawing additional doses information added.
  1. Published